| ARTLX | VIVAX | ARTLX / VIVAX | |
| Total Expense Ratio | 0.99 | 0.17 | 582% |
| Annual Report Gross Expense Ratio | 1.10 | 0.17 | 647% |
| Fund Existence | 20 years | 33 years | - |
| Gain YTD | 9.812 | 10.844 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 317M | 208B | 0% |
| Annual Yield % from dividends | 1.20 | 1.98 | 61% |
| Returns for 1 year | 0.25 | 5.48 | 4% |
| Returns for 3 years | 16.51 | 32.94 | 50% |
| Returns for 5 years | 18.04 | 64.67 | 28% |
| Returns for 10 years | 33.04 | 129.02 | 26% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VGHAX | 85.60 | -0.24 | -0.28% |
| Vanguard Health Care Adm | |||
| USAGX | 43.91 | -0.74 | -1.66% |
| Victory Precious Metals and Minerals | |||
| JSEQX | 51.03 | -0.89 | -1.71% |
| JPMorgan Small Cap Equity R4 | |||
| PMVYX | 20.88 | -0.40 | -1.88% |
| Putnam Sustainable Future Y | |||
| CZMGX | 20.73 | -0.48 | -2.26% |
| Multi-Manager Growth Strategies Inst | |||